Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

NCT01095640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1159

Last updated 2010-03-30

No results posted yet for this study

Summary

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene 0.3% topical gel and the current study is designed to evaluate the safety and efficacy of this formulation.

Conditions

  • Acne Vulgaris

Interventions

DRUG

adapalene 0.3% topical gel

once a day, 84 days

Sponsors & Collaborators

  • Actavis Mid-Atlantic LLC

    lead INDUSTRY

Principal Investigators

  • Vishal B., MD · Yenepoya Medical College

  • Bela J. Shah, MD · GMC and SSG Hospital

  • Mhaske, MD · B. J. Medical College and Hospital

  • Manoj K. Parekh, MD · Bhagwan Mahaveer Jain Hospital

  • V. R. Sardesai, MD · Bharati Vidyapeeth University Medical College & Hospital

  • Kailash Bhatia, MD · Bhatia Skin Laser & Cosmetic Centre

  • Leelavathy B., MD · Bowring & Lady Curzon Hospital

  • Rajkumar V., MD · Dhanawantari Polyclinic

  • Mukta Sachdev, MD · Dr. Mukta Skin Clinic

  • Anilkumar Malik, MD · G.M Modi Hospital

  • Yogesh Marfatia, MD · GMC and SSG Hospital

  • Mahendra M. Kura, MD · Grant Medical College & Sir JJ Group of Hospitals

  • Jayadev Betkerur, MD · J.S.S. Medical College Hospital

  • Manjunath S. M., MD · Justice K.S. Hegde Charitable Hospital

  • Ramesh M., MD · Kempegowda Institute of Medical Sciences

  • Hemanji R. Jerajani, MD · L.T.M. Medical College & General Hospital

  • Vijaykumar Garg, MD · Maulana Azad Medical College Hospital

  • Rajitha K., MD · Medwin Hospital

  • Putta Srinivas, MD · Osmania General Hospital

  • Alur S. Kumar, MD · Owaisi Hospital & Research Centre

  • Jayesh Kothari, MD · Skin Clinic

  • P. V. S. Prasad, MD · Rajah Muthiah Medical College Hospital

  • D. N. Balraj, PI · Rajbal Skin Clinic

  • Sailaja K. Surapaneni, MD · SRI Medical Aesthetic and Cosmetic Surgery

  • Ravi M. Rathod, MD · Skin Care Centre

  • Ranjan C. Raval, MD · Smt. NHL Medical College and V.S. Hospital

  • V. K. Somani, MD · Somani Skin and Cosmetology Institute

  • Rachita Dhurat, MD · T. N. Medical College and BYL Nair hospital

  • P. V. Patalay, MD · Vani Skin Clinic

  • Nataraja, MD · Victoria Hospital

  • Karigi Siddalingappa, MD · Vijayanagara Institute Of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01095640 on ClinicalTrials.gov